Skip to main content
SpringerLink
Log in

Liver Fibrosis Is Associated with Decreased Peripheral Platelet Count in Patients with Chronic Hepatitis B and C

  • CASE REPORT
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Thrombocytopenia is a common complication of chronic liver diseases, but its pathogenesis is not clear. Although generally attributed to hypersplenism, other factors should also be considered. We investigated the relationship between the peripheral platelet count and the degree of fibrosis in patients with chronic viral hepatitis. In an effort to avoid the effects of hypersplenism, we excluded patients with splenomegaly and/or bi- or pan-cytopenia. Seven hundred eighty-four patients (265 chronic viral hepatitis C and 519 chronic viral hepatitis B) were included in the study. Univariate analysis showed that the peripheral platelet count had a negative correlation with fibrosis score, necroinflammatory activity, and age in both groups. In multivariate analysis, the peripheral platelet count had a similar correlation with the fibrosis score and age, but not with necroinflammatory activity, in both groups. The peripheral platelet count decreased more significantly in females with chronic hepatitis C but not in the chronic hepatitis B group. In conclusion, a decrease in peripheral platelet count may be a sign of an increase in the degree of fibrosis during the course of chronic viral hepatitis B and C and factors other than hypersplenism may play a role in this decrease in the peripheral platelet count.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Morlock CG, Hall BE (1943) Association of cirrhosis, thrombocytopenia and hemorrhagic tendency. Arch Intern Med 72:69–77

    Google Scholar 

  2. Felix WR Jr, Myerson RM, Sigel B, Perrin EB, Jackson FC (1974) The effect of portacaval shunt on hypersplenism. Surg Gynecol Obstet 139:899–903

    PubMed  Google Scholar 

  3. Soper NJ, Rikkers LF (1982) Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg 144:70

    Article  Google Scholar 

  4. Morris PW, Patton TB, Balint JA, Hirschowitz BI (1962) Portal hypertension, congestive splenomegaly, and portacaval shunt. Gastroenterology 42:555–559

    Google Scholar 

  5. Mutchnick MG, Lerner E, Conn HO (1980) Effect of portacaval anastamosis on hypersplenism. Dig Dis Sci 25:929–938

    Article  PubMed  CAS  Google Scholar 

  6. Hutson DG, Zeppa R, Levi JU, Schiff ER, Livingstone AS, Fink P (1977) The effect of the distal splenorenal shunt on hypersplenism. Ann Surg 185:605–612

    Article  PubMed  CAS  Google Scholar 

  7. Frick V (1967) Thrombocytopenie und lebercirrhose. Scweiz Med Wochens 97:407–413

    CAS  Google Scholar 

  8. Fiore LD, Brophy MT, Deykin D (2003) Hemostasis. In: Zackim D, Boyer TD (eds) Hepatology: A textbook of liver disease. 4th edn. pp 562–563

  9. Omata M (1998) Screening for hepatocellular carcinoma. In: Advances in therapeutic hepatology: A word view. Postgraduate course book. University of Chicago Press, Chicago, pp. 49–53

    Google Scholar 

  10. Moschcowitz E (1948) The pathogenesis of splenomegaly in hypertension of the portal circulation: “congestive splenomegaly.” Medicine 27:187–221

    PubMed  CAS  Google Scholar 

  11. Landolfi R, Leone G, Fedeli G, Storti S, Laghi F, Bizzi B (1980) Platelet-associated IgG in acute and chronic hepatic diseases. Scand J Haematol 25:417–422

    Article  PubMed  CAS  Google Scholar 

  12. de Noronha R, Taylor BA, Wild G, Triger DR, Greaves M (1991) Interrelationships between platelet count, platelet IgG, serum IgG, immune-complexes and severity of liver disease. Clin Lab Haematol 13:127–135

    Article  PubMed  CAS  Google Scholar 

  13. Skootsky SA, Rosove MH, Langley MB (1986) Immune thrombocytopenia and response to splenectomy in chronic liver disease. Arch Intern Med 146:555–557

    Article  PubMed  CAS  Google Scholar 

  14. Paramo JA, Rocha E (1993) Hemostasis in advanced liver disease. Semin Thromb Hemost 19:184–190

    Article  PubMed  CAS  Google Scholar 

  15. Wehmeier A, Scharf RE, Schneider W (1990) Influence of splenectomy on platelet morphometry and function. Klin Wochenschr 68:847–852

    Article  PubMed  CAS  Google Scholar 

  16. Thomas HC, McSween RN, White RG (1973) Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet 1:1288–1291

    Article  PubMed  CAS  Google Scholar 

  17. Triger DR, Wright R (1973) Hyperglobulinaemia in liver disease. Lancet 1:1494–1496

    Article  PubMed  CAS  Google Scholar 

  18. Kew MC (1996) Hepatitis B and C viruses and hepatocellular carcinoma. Clin Lab Med 16:395–406

    PubMed  CAS  Google Scholar 

  19. MacPherson AI, Innes J (1953) Peripheral blood picture after operation for portal hypertension. Lancet 1:1120–1123

    Article  PubMed  CAS  Google Scholar 

  20. Vang J, Simert G, Hansson JA, Thylen U, Bengmark TS (1977) Results of a modified distal spleno–renal shunt for portal hypertension. Ann Surg 185:224–228

    Article  PubMed  CAS  Google Scholar 

  21. Sullivan BH Jr, Tumen HJ (1961) The effect of portacaval shunt on thrombocytopenia associated with portal hypertension. Ann Intern Med 55:598–603

    PubMed  Google Scholar 

  22. Karasu Z, Gurakar A, Kerwin B, Hulagu S, Jazzar A, McFadden R, Nour B, Sebastian A, Cassidy F, Stokes K, Van Thiel DH, Wright H (2000) Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci 45:1971–1976.

    Google Scholar 

  23. Patton TB, Johnston CG, Lyons C, Jordan P Jr (1959) Lateral portacaval anastomosis for portal hypertension: long term results in 58 patients with intrahepatic portal bed block and 7 patients with extrahepatic portal bed block. Am J Gastroenterol 32:291–310

    PubMed  CAS  Google Scholar 

  24. Puttini M, Marni A, Montes F, Belli L (1979) Effect of portasystemic shunt on hypersplenism: Clinical study in 129 patients with cirrhosis. Am Surg 45:444–448

    PubMed  CAS  Google Scholar 

  25. Ferrara J, Ellison EC, Martin EW Jr, Cooperman M (1979) Correction of hypersplenism following distal splenorenal shunt. Surgery 86:570–573

    PubMed  CAS  Google Scholar 

  26. Malt RA (1976) Portasystemic venous shunts (part 1). N Engl J Med 295:24–29

    Article  PubMed  CAS  Google Scholar 

  27. Marni A, Trojsi C, Belli L (1981) Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism. Am J Surg 142:372–376

    CAS  Google Scholar 

  28. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL (1993) Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 187:413–420

    PubMed  CAS  Google Scholar 

  29. Lawrence SP, Lezotte DC, Durham JD, Kumpe DA, Everson GT, Bilir BM (1995) Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci 40:1575–1580

    Article  CAS  Google Scholar 

  30. Alvarez OA, Lopera GA, Patel V, Encarnacion CE, Palmaz JC, Lee M (1996) Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 91:134–137

    PubMed  CAS  Google Scholar 

  31. Sungaran R, Markovic B, Chong BH (1997) Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization. Blood 89:101–107

    PubMed  CAS  Google Scholar 

  32. Martin TG 3rd, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA (1997) Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 127:285–288

    PubMed  Google Scholar 

  33. Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Langle F, Steininger R, Muhlbacher F, Gangl A (1997) Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 27:127–131

    Article  PubMed  CAS  Google Scholar 

  34. Ishikawa T, Ichida T, Matsuda Y, Sugitani S, Sugiyama M, Kato T, Miyazaki H, Asakura H (1998) Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol 13:907–913

    PubMed  CAS  Google Scholar 

  35. Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M, Hocker P, Panzer S (1998) Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest 28:755–759

    Article  PubMed  CAS  Google Scholar 

  36. Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, Makowka L, Todo S, Gordon RD, Iwatsuki S (1989) Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 210:180–183

    Article  PubMed  CAS  Google Scholar 

  37. Hutchison DE, Genton E, Porter KA, Daloze PM, Huguet C, Brettschneider L, Groth CG, Starzl TE (1968) Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg 97:27–33

    PubMed  CAS  Google Scholar 

  38. Rinkes IH, Van der Hoop AG, Hesselink EJ, Metselaar H, De Rave S, Zonderland HM, Schalm SW, Terpstra OT (1991) Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension? Gastroenterology 100:1126–1128

    Google Scholar 

  39. Ono E, Shiratori Y, Okudaira T, Imamura M, Teratani T, Kanai F, Kato N, Yoshida Y, Shiina S, Omata M (1999) Platelet count reflects stage of chronic hepatitis C. Hepatol Res 15:192–200

    Article  Google Scholar 

  40. Matsumuro H, Moriyama M, Goto I, Tanaka N, Okubo H, Arakawa Y (2000) Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C—a study of 527 patients at one establishment. J Viral Hepat 7:268–275

    Article  Google Scholar 

  41. Okubo M, Shiota G, Kawasaki H (2000) Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma. Clin Sci (Lond) 99:207–214

    Article  CAS  Google Scholar 

  42. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T (2001) Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 96:3142–3146

    Article  PubMed  CAS  Google Scholar 

  43. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435

    Article  PubMed  CAS  Google Scholar 

  44. Fusegawa H, Shiraishi K, Ogasawara F, Shimizu M, Haruki Y, Miyachi H, Matsuzaki S, Ando Y (2002) Platelet activation in patients with chronic hepatitis C. Tokai J Exp Clin Med 27:101–106

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Ege University Medical School, Izmir, Turkey

    Zeki Karasu, Fatih Tekin, Galip Ersoz, Fulya Gunsar, Yucel Batur, Tankut Ilter & Ulus S. Akarca

  2. Ege Üniversites i Tıp Fakültesi, Gastroenteroloji Bilim Dalı, Bornova, 35100, Izmir, Turkey

    Zeki Karasu

Authors
  1. Zeki Karasu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fatih Tekin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Galip Ersoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fulya Gunsar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yucel Batur
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tankut Ilter
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ulus S. Akarca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zeki Karasu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karasu, Z., Tekin, F., Ersoz, G. et al. Liver Fibrosis Is Associated with Decreased Peripheral Platelet Count in Patients with Chronic Hepatitis B and C. Dig Dis Sci 52, 1535–1539 (2007). https://doi.org/10.1007/s10620-006-9144-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9144-y

Keywords

Search

Navigation